Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Tsuchimoto A, Noguchi H, Hirakata H, Tsuruya K, Kitazono T.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2082-90. doi: 10.2215/CJN.03480413. Epub 2013 Oct 31.

2.

Association of C4d deposition with clinical outcomes in IgA nephropathy.

Espinosa M, Ortega R, Sánchez M, Segarra A, Salcedo MT, González F, Camacho R, Valdivia MA, Cabrera R, López K, Pinedo F, Gutierrez E, Valera A, Leon M, Cobo MA, Rodriguez R, Ballarín J, Arce Y, García B, Muñoz MD, Praga M; Spanish Group for Study of Glomerular Diseases (GLOSEN).

Clin J Am Soc Nephrol. 2014 May;9(5):897-904. doi: 10.2215/CJN.09710913. Epub 2014 Feb 27.

3.

The use of the Oxford classification of IgA nephropathy to predict renal survival.

Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2384-8. doi: 10.2215/CJN.01170211. Epub 2011 Sep 1.

4.

Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.

Zhang J, Wang C, Tang Y, Peng H, Ye ZC, Li CC, Lou TQ.

Nephrology (Carlton). 2013 Feb;18(2):125-31. doi: 10.1111/nep.12010.

PMID:
23134230
5.

Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).

Edström Halling S, Söderberg MP, Berg UB.

Nephrol Dial Transplant. 2012 Feb;27(2):715-22. doi: 10.1093/ndt/gfr339. Epub 2011 Jul 12.

6.

Clinical implication of crescentic lesions in immunoglobulin A nephropathy.

Lee MJ, Kim SJ, Oh HJ, Ko KI, Koo HM, Kim CH, Doh FM, Yoo TH, Kang SW, Choi KH, Lim BJ, Jeong HJ, Han SH.

Nephrol Dial Transplant. 2014 Feb;29(2):356-64. doi: 10.1093/ndt/gft398. Epub 2013 Sep 29.

7.

Validation of the Oxford classification of IgA nephropathy.

Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC.

Kidney Int. 2011 Aug;80(3):310-7. doi: 10.1038/ki.2011.126. Epub 2011 May 4.

8.

Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults.

Lee H, Yi SH, Seo MS, Hyun JN, Jeon JS, Noh H, Han DC, Hwang SD, Jin SY, Kwon SH.

Korean J Intern Med. 2012 Sep;27(3):293-300. Epub 2012 Sep 1.

9.

Clinical outcomes and predictors for ESRD and mortality in primary GN.

Chou YH, Lien YC, Hu FC, Lin WC, Kao CC, Lai CF, Chiang WC, Lin SL, Tsai TJ, Wu KD, Chen YM.

Clin J Am Soc Nephrol. 2012 Sep;7(9):1401-8. Epub 2012 Jul 12.

10.

High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.

Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.

Korean J Intern Med. 2015 May;30(3):354-61. doi: 10.3904/kjim.2015.30.3.354. Epub 2015 Apr 29.

11.

A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.

Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.

Am J Kidney Dis. 2007 Jun;49(6):763-75.

PMID:
17533019
12.

Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.

Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.

J Nephrol. 2012 Sep-Oct;25(5):810-8. doi: 10.5301/jn.5000069.

PMID:
22252844
13.

Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.

Lv J, Shi S, Xu D, Zhang H, Troyanov S, Cattran DC, Wang H.

Am J Kidney Dis. 2013 Nov;62(5):891-9. doi: 10.1053/j.ajkd.2013.04.021. Epub 2013 Jun 29. Review.

PMID:
23820066
14.

Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.

Le W, Zeng CH, Liu Z, Liu D, Yang Q, Lin RX, Xia ZK, Fan ZM, Zhu G, Wu Y, Xu H, Zhai Y, Ding Y, Yang X, Liang S, Chen H, Xu F, Huang Q, Shen H, Wang J, Fogo AB, Liu ZH.

BMC Nephrol. 2012 Nov 27;13:158. doi: 10.1186/1471-2369-13-158.

15.

Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.

Park KS, Han SH, Kie JH, Nam KH, Lee MJ, Lim BJ, Kwon YE, Kim YL, An SY, Kim CH, Doh FM, Koo HM, Oh HJ, Kang SW, Choi KH, Jeong HJ, Yoo TH.

Hum Pathol. 2014 Feb;45(2):236-43. doi: 10.1016/j.humpath.2013.08.019.

PMID:
24439222
16.

Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy.

Park GY, Yu CH, Kim JS, Kang YJ, Kwon O, Choi JY, Cho JH, Kim CD, Kim YL, Park SH.

Korean J Intern Med. 2015 May;30(3):345-53. doi: 10.3904/kjim.2015.30.3.345. Epub 2015 Apr 29.

17.

Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.

Barbour SJ, Cattran DC, Kim SJ, Levin A, Wald R, Hladunewich MA, Reich HN.

Kidney Int. 2013 Nov;84(5):1017-24. doi: 10.1038/ki.2013.210. Epub 2013 Jun 5. Erratum in: Kidney Int. 2015 Jan;87(1):242.

PMID:
23739233
18.

Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study.

Lv J, Yang Y, Zhang H, Chen W, Pan X, Guo Z, Wang C, Li S, Zhang J, Zhang J, Liu L, Shi S, Wang S, Chen M, Cui Z, Chen N, Yu X, Zhao M, Wang H.

J Am Soc Nephrol. 2013 Dec;24(12):2118-25. doi: 10.1681/ASN.2012101017. Epub 2013 Sep 12.

19.

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.

Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, Lunberg S, Gesualdo L, Emma F, Rollino C, Amore A, Praga M, Feriozzi S, Segoloni G, Pani A, Cancarini G, Durlik M, Moggia E, Mazzucco G, Giannakakis C, Honsova E, Sundelin BB, Di Palma AM, Ferrario F, Gutierrez E, Asunis AM, Barratt J, Tardanico R, Perkowska-Ptasinska A; VALIGA study of the ERA-EDTA Immunonephrology Working Group.

Kidney Int. 2014 Oct;86(4):828-36. doi: 10.1038/ki.2014.63. Epub 2014 Apr 2.

20.

Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.

Knoop T, Vågane AM, Vikse BE, Svarstad E, Magnúsdóttir BT, Leh S, Varberg Reisæter A, Bjørneklett R.

Am J Nephrol. 2015;41(3):210-9. doi: 10.1159/000381403. Epub 2015 Apr 9.

Items per page

Supplemental Content

Write to the Help Desk